Barclays
ORGN

Barclays’s Origin Materials ORGN Stock Holding History

Barclays’s Portfolio ORGN Stock Details ORGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39 Buy
39
+38
+3,800% +$62 ﹤0.01% 5259
2026
Q1 		$2 Buy
+1
New +$5 ﹤0.01% 4994
2025
Q4 		– Hold
0
– – – 5557
2025
Q3 		– Hold
0
– – – 5449
2025
Q2 		– Sell
-43
Closed -$728 – 5458
2025
Q1 		$865 Sell
43
-964
-96% -$26.5K ﹤0.01% 5057
2024
Q4 		$38.7K Buy
+1,007
New +$38.2K ﹤0.01% 4812
2024
Q3 		– Sell
-1,297
Closed -$47K – 5259
2024
Q2 		$35.1K Sell
1,297
-1,441
-53% -$38.5K ﹤0.01% 4324
2024
Q1 		$41.9K Sell
2,738
-2,616
-49% -$45.4K ﹤0.01% 4650
2023
Q4 		$134K Buy
5,354
+3,964
+285% +$114K ﹤0.01% 4555
2023
Q3 		$53.4K Buy
1,390
+41
+3% +$3.22K ﹤0.01% 3844
2023
Q2 		$172K Sell
1,349
-423
-24% -$54.5K ﹤0.01% 3315
2023
Q1 		$227K Buy
1,772
+832
+89% +$123K ﹤0.01% 3716
2022
Q4 		$130K Sell
940
-1,656
-64% -$264K ﹤0.01% 4077
2022
Q3 		$402K Buy
2,596
+123
+5% +$21.8K ﹤0.01% 2825
2022
Q2 		$380K Sell
2,473
-102
-4% -$19.4K ﹤0.01% 3050
2022
Q1 		$508K Buy
+2,575
New +$449K ﹤0.01% 2898

Other funds holding ORGN

AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Barclays's ORGN Position: Q2 2026 in Review

Barclays increased its Origin Materials (ORGN) stake by 3,800% in Q2 2026, buying an estimated $62 and bringing the position to 39 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #5259.

Barclays first reported a position in ORGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $508K in Q1 2022. 38 funds tracked by Wall St. Rank hold ORGN as of Q2 2026.

  • Barclays held 39 shares of Origin Materials worth $39 as of Q2 2026.
  • Barclays bought 38 Origin Materials shares in Q2 2026, an estimated $62.
  • Origin Materials made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5259 holding.
  • Barclays first reported a position in Origin Materials in Q1 2022 and has held it in 14 quarters since.
  • Barclays's Origin Materials position peaked at $508K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Origin Materials as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.